Review top news and interview highlights from the week ending October 28, 2022.
Welcome to CGTLive’s Weekly Rewind! We’ve compiled 5 highlights from this week’s coverage of advances in gene and cell therapies, including FDA actions, notable research, and interviews with experts across the field.
The trial is being conducted at the University of California – San Diego under the leadership of Stephanie Cherqui, PhD.
The chief scientific officer of Excision BioTherapeutics discussed the phase 1/2 clinical trial of the CRISPR gene editing therapy.
CGTLive highlights the PROVIDE trial of PR001 for Gaucher Awareness Month.
The pediatrician from Royal Manchester Children’s Hospital discussed progress with the PROVIDE trial of PR001.
The trial expects to enroll its first patient in the first half of 2023.